Physician profile
Ryan Daly
NPI 1598937484
$18,657.19
in general payments reported to CMS, 2019-2025
28 companies · $717 in 2025
The $717 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,484 · 2020: $5,306 · 2021: $4,282 · 2022: $467 · 2023: $653 · 2024: $748 · 2025: $717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,082 · Travel and Lodging: $36.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,081.63 |
| Travel and Lodging | $36.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $15,116.61 | 2019-2025 | Farxiga, Brilinta |
| Novartis Pharmaceuticals Corporation | $483.33 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $448.26 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $404.65 | 2019-2025 | Opdivo, Camzyos, Eliquis |
| Heartflow, INC. | $301.25 | 2019-2025 | |
| Amgen INC. | $282.07 | 2020-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $231.25 | 2019-2025 | Watchman Flx, Watchman Access System |
| Siemens Medical Solutions USA, INC. | $227.70 | 2024 | Naeotom Alpha |
| Pfizer INC. | $192.48 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $153.31 | 2019-2025 | Verquvo |
| Cleerly, INC. | $129.41 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Novo Nordisk INC | $121.77 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.74 | 2022-2025 | Jardiance |
| Ge Healthcare | $78.79 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $61.95 | 2021-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $45.35 | 2024-2025 | Assure Wcd |
| Amarin Pharma, INC. | $44.33 | 2020-2021 | |
| Philips North America LLC | $37.67 | 2019 | |
| Abbott Laboratories | $34.05 | 2024-2025 | Mitraclip |
| Lexicon Pharmaceuticals, INC. | $30.76 | 2023-2024 | Inpefa |
| Terumo Medical Corporation | $26.41 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.55 | 2023 | Xifaxan |
| Lilly USA, LLC | $16.98 | 2025 | Zepbound |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.92 | 2021-2025 | Lifevest |
| Esperion Therapeutics, INC. | $14.67 | 2024 | Nexletol |
| Kiniksa Pharmaceuticals International, Plc | $14.17 | 2024 | Arcalyst |
| Ucb, INC. | $13.13 | 2019 | |
| Lantheus Medical Imaging, INC. | $12.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Daly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.